Showing results (231-240 of 308) with videos related to

Sort By:
Pageof 31
Journal of Gastroenterology and Hepatology|November 19, 2016
Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablationYu Rim Lee, Soo Young Park, Seung Up Kim, et al.
Clinical and Molecular Hepatology|April 16, 2024
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysisHarry Crane, Guy D Eslick, Cameron Gofton, et al.
European Journal of Gastroenterology & Hepatology|November 26, 2019
Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolizationJae Seung Lee, Han Ah Lee, Mi Young Jeon, et al.
Diagnostics (Basel, Switzerland)|January 8, 2023
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related CirrhosisJae Seung Lee, Tae Seop Lim, Hye Won Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2009
What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South KoreaSeung Up Kim, Gi Hong Choi, Woong Kyu Han, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 14, 2022
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related CirrhosisMi Na Kim, Jae Seung Lee, Hye Won Lee, et al.
Hepatology (Baltimore, Md.)|May 19, 2023
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort studyBeom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, et al.
Plos One|April 5, 2019
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resectionMi Young Jeon, Hye Soo Kim, Tae Seop Lim, et al.
Cancers|September 28, 2021
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseJae Seung Lee, Dong Hyun Sinn, Soo Young Park, et al.
Gastroenterology Report|August 19, 2022
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease modelSang Hyun Seo, Da Hyun Lee, Yu Seol Lee, et al.
Pageof 31